PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 1 month ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 1 month ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 year 2 months ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 1 year 2 months ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 1 year 3 months ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
BRIEF published on 02/21/2025 at 07:05, 1 year 3 months ago BB Biotech Navigates Biotech Sector's Early Recovery in 2024 Investment Strategy 2024 Financial Performance BB Biotech Regulatory Milestones Biotech Recovery
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 3 months ago EQS-Adhoc: BB Biotech AG publishes its 2024 annual report BB Biotech AG publishes its 2024 annual report, revealing financial performance and proposed dividend. Report includes biotech sector overview and investment details Biotechnology Investment Dividend BB Biotech AG 2024 Annual Report
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 3 months ago Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics BB Biotech's 2024 Annual Report highlights the company's strategic positioning for sector recovery amid shifting market dynamics, including key milestones and financial results Annual Report Investment Performance Sector Recovery Market Dynamics BB Biotech
BRIEF published on 01/24/2025 at 07:05, 1 year 4 months ago BB Biotech: 2024 Results and Dividend Proposal Overview Dividend Proposal Biotech Sector BB Biotech Investor Sentiment 2024 Results
BRIEF published on 01/24/2025 at 07:05, 1 year 4 months ago BB Biotech AG Reports Profit in 2024 Fiscal Year Financial Results Investment Performance BB Biotech AG 2024 Fiscal Profit Drug Developers
Published on 06/03/2026 at 10:30, 1 hour 7 minutes ago Silver Range Partner Excalibur Metals Intersects a Broad Precious Metals Zone, Open at Depth at the Bellehelen Property
Published on 06/03/2026 at 10:00, 1 hour 37 minutes ago Eagle Plains and Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, SK
Published on 06/03/2026 at 09:01, 2 hours 36 minutes ago Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Published on 06/03/2026 at 04:58, 6 hours 39 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 10:20, 1 hour 16 minutes ago WasabiCard, Payment Unicorn-in-the-making, Closes Pre-A, backed by Vernal Capital and Avenir Group, Vision Plus Capital, and 01VC
Published on 06/03/2026 at 10:15, 1 hour 21 minutes ago Red Bull Basement Is Helping Founders Vibe Code Their Idea Into a Funded Startup Reality
Published on 06/03/2026 at 10:15, 1 hour 22 minutes ago TenneT Germany receives MSCI ESG rating of AA
Published on 06/03/2026 at 11:29, 8 minutes ago 2026.06.03 Notice to holders of the Convertible Bond ISIN FR0013521085
Published on 06/03/2026 at 08:45, 2 hours 52 minutes ago Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 17 hours 33 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 17 hours 55 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 17 hours 57 minutes ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
